Drug Shortage Report for AVANDIA

Last updated on 2020-04-24 History
Report ID 69611
Drug Identification Number 02241114
Brand name AVANDIA
Common or Proper name rosiglitazone (as rosiglitazone maleate) tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) ROSIGLITAZONE
Strength(s) 8MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60's
ATC code A10BG
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-05-01
Estimated end date Unknown
Actual end date 2020-04-22
Shortage status Resolved
Updated date 2020-04-24
Company comments This product has been discontinued
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2020-04-24 French Compare
v14 2020-04-24 English Compare
v13 2020-02-27 French Compare
v12 2020-02-27 English Compare
v11 2019-10-18 French Compare
v10 2019-10-18 English Compare
v9 2019-07-10 French Compare
v8 2019-07-10 English Compare
v7 2019-05-02 English Compare
v6 2019-05-01 French Compare
v5 2019-05-01 English Compare
v4 2019-04-10 French Compare
v3 2019-04-10 English Compare
v2 2018-12-14 French Compare
v1 2018-12-14 English Compare

Showing 1 to 15 of 15